tradingkey.logo
tradingkey.logo
検索

Balchem Corp

BCPC
ウォッチリストに追加
168.800USD
-0.090-0.05%
終値 07/02, 13:00ET15分遅れの株価
5.42B時価総額
34.32直近12ヶ月PER

詳細情報 Balchem Corp 企業名

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Balchem Corpの企業情報

企業コードBCPC
会社名Balchem Corp
上場日Jun 03, 1986
最高経営責任者「CEO」Harris (Theodore L)
従業員数1361
証券種類Ordinary Share
決算期末Jun 03
本社所在地- -
都市- -
証券取引所NASDAQ OMX - NASDAQ BASIC
- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コードBCPC
上場日Jun 03, 1986
最高経営責任者「CEO」Harris (Theodore L)

Balchem Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Kathleen B. Fish
Ms. Kathleen B. Fish
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%

よくある質問

Balchem Corpの上位5名の株主は誰ですか?

Balchem Corpの上位5名の株主は以下のとおりです。Mr. Theodore L. (Ted) Harris

Balchem Corp(BCPC)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Balchem Corpの株式を保有している機関は741社あり、保有株式の総市場価値は約28.38Mで、全体の88.34%を占めています。2025Q4と比較して、機関の持ち株は-2011669.00増加しています。

Balchem Corpの最大の収益源は何ですか?

2026Q1において、Product Sales Revenue部門がBalchem Corpにとって最大の収益を生み出しており、その金額は1.04Bで、全収益の99.82%を占めています。